• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
The Neurodiagnostics Report 2012: Brain Imaging, Biomarkers and NeuroInformatics - Product Image

The Neurodiagnostics Report 2012: Brain Imaging, Biomarkers and NeuroInformatics

  • ID: 2120879
  • April 2012
  • Region: Global
  • NeuroInsights

FEATURED COMPANIES

  • 3andMe
  • Biosite
  • Diagenic
  • J
  • Neuronetrix
  • Rules-Based Medicine
  • MORE

Fully updated third annual industry insider report detailing markets and emerging diagnostics in neurology and psychiatry.

Nearly 2 billion people worldwide and 100 million people in the US are affected by a brain or nervous system disorder including addiction, Alzheimer’s, depression, anxiety, schizophrenia, attention disorders, epilepsy, Parkinson’s disease, sensory disorders, and sleep disorders. Diagnosis of these disorders is rapidly changing as new tools are developed for more objective and personalized assessment and treatment.

In addition to the massive unmet markets, long term growth in neurodiagnostics is being driven by 1) technology advances and equipment upgrades in neuroimaging, 2) new biomarkers and imaging protocols for early diagnosis and disease monitoring, and 3) increased use of imaging and informatics in drug and device development.

Over 150 Companies Included

NeuroInsights has identified three primary markets in neurodiagnostics which are discussed in detail in this report:

- Neuroimaging: Medical equipment and reagents for research, diagnostics and patient monitoring, including MRI, CT, PET, SPECT, EEG and MEG.
- In vitro diagnostics: Genetic testing, biomarker assays and chemical profiling of human samples, including urine, blood, cerebral spinal fluid and tissue.
- Neuroinformatics: Multidimensional databases and software systems that store and analyze data from the genetic to the behavioral level.

FEATURED COMPANIES

  • 3andMe
  • Biosite
  • Diagenic
  • J
  • Neuronetrix
  • Rules-Based Medicine
  • MORE

1 Neurodiagnostic Markets
Sector Overview
Neurodiagnostics Industry Taxonomy
FDA Approval and Reimbursement of Diagnostics
Market Opportunities in Neurology and Psychiatry
Number of People impacted by Neurological and Psychiatric Disorders, WW and US
Neurology Markets and Emerging Diagnostics
- Alzheimer's
- Autism
- Traumatic Brain Injury
Psychiatry Markets and Emerging Diagnostics
- Depression

2 Neuroimaging
Medical Divisions of Fortune 500 Companies Dominate
Computed Tomography (CT)
Nuclear Medicine Imaging (PET, SPECT)
Electro-encephalography (EEG)
Magneto-encephalography (MEG)
Neurolens Open Source Brain Imaging Software

3 In Vitro Diagnostics
In Vitro Diagnostics Regulatory Landscape
Genetic Testing and Pharmacogenomics
Protein Biomarker Assays
Pattern Recognition in Diagnostics

4 Neuroinformatics
Databases
Neuroinformatics Data Storage
Paul Allen Brain Atlas Project
IBM Blue Brain Project
Diagnostic Software

5 Investing in Neurodiagnostics
Venture Capital Investment
Neurodiagnostic Venture Financings, Companies and Investors 2005-2011
Public Investment Activity and IPOs
Diagnostic Initial Public Offerings (IPOs), 2004 - 2011
Public Neurodiagnostic Related Companies, Stock Performance and Fundamentals
Merger and Acquisition Activity

6 Company Profiles
Neurodiagnostic Companies: Private
Neurodiagnostic Companies: Public

3andMe
3M

A
AbaStar MDx
Abbot Diagnostics
Abbott
Abiant
AccSys Technology
Adlyfe
Advanced Brain Monitoring
Affymetrix
Allen Institute for Brain Science
Alpine
ALS Association
Alseres
Alzheimer’s Association
Amersham
Aposense
Applied NeuroSolutions
Aspect Medical
AssureRx
AstraZeneca
Astro-Med
AsuraGen
Athena Diagnostics
Avacta
Avid Radiopharmaceuticals

B
Banyan Biomarkers
Bayer
BD Diagnostics
Beckman Coulter
Biancamed
Bioasis
BioBehavioral Diagnostics
BioDirection
bioMerieux
Bio-Rad
Biosite
Blackrock Neuromed
Blue Marble Game Company
Bracco Diagnostics
Brain Resource
BrainGate Company
BrainLab
BrainLAB
BrainScope
BrainZ Instruments

C
Cadwell Laboratories
Cambridge Cognition
Carefusion
Catalina Imaging
CCBR-Synarc
Checkpoint Surgical
Cholestech
Chronix
Cleveland Medical
Cleveland Medical Devices
Clino, Ltd.
CNS Response
CNS Vital Signs
Codman
Cognitive Drug Research
CogState
Compumedics
Cornell University
Cortech
Cortech Solutions
Covidien
CTI Molecular Imaging
Cytox

D
Dade Behring
deCODE genetics ehf
Diagenic
DNATraits
Dormir
Durin Technologies

E
EEG Spectrum
Eisai
Elan
Electrical Geodesics
Elekta
Eli Lilly
ElMindA
Emotiv
Emsense
Everest Medical
ExonHit

F
Fisher Scientific
Fonar Corporation

G
GE
GE Healthcare
GeneNews
Genizon
GlaxoSmithKline
Grasstechnologies

H
Heidelberg Engineering
Hemosense
Hitachi

I
IDX Systems
Impulse Monitoring
Infrascan
Inverness Medical
Ischemia Care
Ixico

J
Jan Medical
Johnson & Johnson
Jordan Neuroscience

K
Kappametrics

L
LA MONT Medical
Leap Medica
Lexicor Medical
Lineagen

M
M.J. Fox Foundation
McKesson
Medic Vision
Medtronic
Merck
Merge Healthcare
Merz Pharma
Metabolon
Mind Research Network
Molecular Insight Pharma
Molecular Neuroimaging
Molecular Vision
Myriad RBM

N
Natus
Navigenics
Neural Signals
Neuralynx
Neuro Kinetics
Neurodyne
Neurolink
NeuroLogica
Neurolutions
NeuroMark
NeuroMetrix
Neuronetrix
Neuroptics
Neuroptix
Neuroscan
NeuroSky
Neurotech
NeuroTrax
NeuroVigil
NeuroVista
New Jersey Science and Technology University
Nexstim
Nicolet Biomedical
Nihon Kohden
NimbleGen
Novartis
Novasom
Nymox

O
Odin
Olympic Medical
Optima Neuroscience
Optimal Medicine
Orasi Medical
Ortho-Clinical Diagnostics
Oxford

P
Parkinson’s Institute
Pediatric Bioscience
Pfizer
Philips
PhysioSonics
Positron
Pritzker Neuropsychiatric Disorders Research Consortium
Psynomics
Psynova

Q
Quest Diagnostics

R
Ridge Diagnostics
Roche
Rules-Based Medicine

S
Satoris
SEDline
SeqWright
Shimadzu Medical Systems
Siemens
SleepMed
SmartBrain Technologies
Stanford University
Stryker
SureGene
SynapDx
Synarc
Sysmex

T
TeraRecon
TheraGenetics
Toshiba
Transcription Diagnostics

U
UC Davis
UC Irvine
UCLA
United Biosource
University of Cambridge
University of Michigan

V
Vanda
Varian Medical Systems
Viasys
Vitapath

W
Wyeth

X
Xltek

Z
Zeo

Question Does this product have a particular geographic focus?
Answer The product is focused on technologies in development at companies worldwide. The report does discuss worldwide markets but is more focused on the competitive landscape than detailing specific market numbers in various regions.
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos